Mirae Asset Global Investments
NAUT icon

Mirae Asset Global Investments’s Nautilus Biotechnolgy NAUT Stock Holding History

Mirae Asset Global Investments’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,536
Closed -$13.2K – 1640
2024
Q3 		$13.2K Buy
4,536
+796
+21% +$2.06K ﹤0.01% 1485
2024
Q2 		$8.53K Buy
+3,740
New +$9.77K ﹤0.01% 1469
2021
Q1 		– Sell
-16,068
Closed -$174K – 1582
2020
Q4 		$174K Buy
+16,068
New +$169K ﹤0.01% 1528

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments's NAUT Position: Q4 2024 in Review

Mirae Asset Global Investments sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 4,536 shares — an estimated $13.2K sold.

Mirae Asset Global Investments first reported a position in NAUT in Q4 2020 and held it in 3 quarters. The position peaked at $174K in Q4 2020. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

  • Mirae Asset Global Investments reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,536 Nautilus Biotechnolgy shares in Q4 2024, an estimated $13.2K.
  • Mirae Asset Global Investments first reported a position in Nautilus Biotechnolgy in Q4 2020 and held it in 3 quarters.
  • Mirae Asset Global Investments's Nautilus Biotechnolgy position peaked at $174K in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.